News

Delivering complex drugs directly to the brain – technology breakthrough being commercialised by Isis

21st March 2011

All News | Technology News

Oxford University scientists have developed a new method for delivering complex drugs directly to the brain, a necessary step for treating diseases like Alzheimer’s, Parkinson’s, Motor Neuron Disease and Muscular Dystrophy.

Healthcare Imaging Technology from Oxford Provides Superior Performance at Lower Cost

14th March 2011

All News | Spinouts & Startups | Technology News

Oxford Electromagnetic Acoustic Imaging (OxEMA) is a patented healthcare imaging technology offering superior diagnostic power to conventional ultrasound systems and MRI-like images.

Isis Spin-out Zyoxel Announces Global Launch of TissueFlex

10th March 2011

All News | Financial News | Spinouts & Startups | Technology News

TissueFlex® addresses the missing link between conventional 2D assays and in vivo studies, providing a true three-dimensional (3D) platform for in vitro cultures with more in vivo-like behaviour to improve the predictivity of drug safety and efficacy testing.

Colwiz Launched Through the Isis Software Incubator

9th March 2011

All News | Startup Incubator | Technology News

Colwiz (Collective Wizdom) gives researchers an integrated suite of tools to collaborate efficiently and quickly with colleagues scattered around the world and working in a variety of different research areas.

Isis Spin-out Oxford Catalysts Announce £21m Fund Raising

8th March 2011

All News | Spinouts & Startups | Technology News

Oxford Catalysts spun-out from the University of Oxford by Oxford University Innovation Ltd in 2006, has announced a further funding round to progress from operating as a research and development company to a commercial product company.

Oxford spin-out OrganOx raises new funding

7th February 2011

All News | Financial News | Spinouts & Startups | Technology News

OrganOx Ltd, spun-out of the University of Oxford by Oxford University Innovation Ltd in 2008, has completed a Series B investment round of £2.75m. The round, which was over-subscribed, was supported by existing shareholders and a number of new ones, including the Royal Society.

Isis signs exclusive worldwide drug delivery licence with Oxford Nutrascience

4th February 2011

All News | Technology News

Oxford Nutrascience Group plc has signed a worldwide exclusive licensing agreement with Oxford University Innovation Limited, the technology transfer company wholly-owned by the University of Oxford, to develop and commercialise products utilizing a novel drug delivery technology.

Cella Energy Ltd – Developing Safe, Low-cost Hydrogen Storage

3rd February 2011

All News | Technology News

Cella Energy Ltd, is developing a hydrogen storage material that is environmentally friendly and can potentially be used to provide hydrogen fuel for internal combustion engines. The technology is stable and safe, with hydrogen encapsulated in a hydride core by a polymer shell that controls the storage and release processes.

Laing O’Rourke Investment in the University of Oxford

26th January 2011

All News | Technology News

The Laing O’Rourke Centre for Construction Engineering will build on existing expertise at Oxford’s Department of Engineering Science and other departments around the University, such as the Department of Materials and the Oxford e-Research Centre, to improve construction methods and processes.

Licensing Success for Isis Outcomes

11th January 2011

All News | Clinical Outcomes | Technology News

The Great Ormond Street Hospital for Children has become the 100th licensee this financial year of health questionnaires created in Oxford.

News

Ready to get in touch?